Raphael Pharmaceutical Inc.
For the period ended Mar 31, 2026. Filed May 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 14, 2026
RAPHStored price and day change unavailable
Contents
Item 1. Financial Statements
RAPHAEL PHARMACEUTICAL INC. AND ITS SUBSIDIARY
CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
AS OF MARCH 31, 2026
UNAUDITED
U.S. DOLLARS IN THOUSANDS
INDEX
| Page | |
| Condensed Consolidated Interim Balance Sheets | F-1 |
|---|---|
| Condensed Consolidated Interim Statements of Comprehensive Loss | F-2 |
| Condensed Consolidated Interim Statements of Changes in Stockholders’ Equity | F-3 |
| Condensed Consolidated Interim Statements of Cash Flows | F-4 |
| Notes to Condensed Consolidated Interim Financial Statements | F-5 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.